Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Serge Guzy"'
Autor:
Inessa Semenenko, Emma Portnoy, Mohammed AbouKaoud, Serge Guzy, Miri Shmuel, Gal Itzhak, Sara Eyal
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Aim: The multidrug resistance protein 1 (MDR1; P-glycoprotein) has been associated with efflux of chemotherapeutic agents from tumor cells and poor patient prognosis. This study evaluated the feasibility of non-invasive, non-radioactive near infrared
Externí odkaz:
https://doaj.org/article/cb6d7ef332a24bf58a2fbbb946a1538e
Autor:
Thomas P. Young, Joel S. Erickson, Shannon L. Hattan, Serge Guzy, Fabienne Hershkowitz, Michael D. Steward
Publikováno v:
Cannabis and Cannabinoid Research.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christine Falcoz, Serge Guzy, Jana Kovač, Isabel Meister, Jean Coulibaly, Somphou Sayasone, David Wesche, Yu-Wei Lin, Jennifer Keiser
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 49(3)
Racemic praziquantel (PZQ) is the standard treatment for schistosomiasis and liver fluke infections (opisthorchiasis and clonorchiasis). The development of an optimal pediatric formulation and dose selection would benefit from a population pharmacoki
Autor:
Christine Falcoz, Serge Guzy, Jana Kovač, Isabel Meister, Jean Coulibaly, Somphou Sayasone, David Wesche, Yu-Wei Lin, Jennifer Keiser
Publikováno v:
Journal of Pharmacokinetics and Pharmacodynamics. 49:395-395
Autor:
Hooman Beygi, Igor D. Grachev, Juha-Matti Savola, Micha Levi, Serge Guzy, Margaret Bradbury, Pippa S. Loupe, Lavi Erisson, Ofer Spiegelstein, Maria Velinova, Spyros Papapetropoulos, William Tracewell, Mirna McDonald, Orit Cohen-Barak, Frank Schneider
Publikováno v:
British Journal of Clinical Pharmacology. 84:2422-2432
AIMS SD-1077, a selectively deuterated precursor of dopamine (DA) structurally related to L-3,4-dihydroxyphenylalanine (L-DOPA), is under development for treatment of motor symptoms of Parkinson's disease. Preclinical models have shown slower metabol
Autor:
Garry A. Neil, Serge Guzy, Pablo E. Pergola, Shany Blum, Belly Koren, Abraham Nyska, Gil Chernin, Keren Doenyas-Barak, Reem Miari, Yoram Yagil, Doron Schwartz, Nir Shapir, Benny Lerner, Shai Efrati
Publikováno v:
New England Journal of Medicine. 376:189-191
A new protein-delivery platform can provide sustained secretion of recombinant human erythropoietin with the use of small, transduced autologous dermal implants. Study patients with end-stage renal disease were found to have maintenance of stable hem
Autor:
Frank, Schneider, Lavi, Erisson, Hooman, Beygi, Margaret, Bradbury, Orit, Cohen-Barak, Igor D, Grachev, Serge, Guzy, Pippa S, Loupe, Micha, Levi, Mirna, McDonald, Juha-Matti, Savola, Spyros, Papapetropoulos, William G, Tracewell, Maria, Velinova, Ofer, Spiegelstein
Publikováno v:
British journal of clinical pharmacology. 84(10)
SD-1077, a selectively deuterated precursor of dopamine (DA) structurally related to L-3,4-dihydroxyphenylalanine (L-DOPA), is under development for treatment of motor symptoms of Parkinson's disease. Preclinical models have shown slower metabolism o
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 45(2)
A distributed delay approach was proposed in this paper to model delayed outcomes in pharmacokinetics and pharmacodynamics studies. This approach was shown to be general enough to incorporate a wide array of pharmacokinetic and pharmacodynamic models
Autor:
Serge Guzy, Robert J. Bauer
Publikováno v:
Statistical Methods in Healthcare